QamarJKhanMD

Oncology • Fairway, KS

Associate Professor, Internal Medicine, University Kansas School of Medicine

Join to view full profile

Dr. Khan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Khan's full profile

Already have an account?

Office
2330 Shawnee Mission Pkwy
Ste 210
Fairway, KS 66205
Phone+1 913-588-6000
Is this information wrong?

Education & Training

University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2004
Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 1993 - 1997
King Edward Medical UniversityClass of 1986

Certifications & Licensure

MO State Medical License 2021 - 2025
KS State Medical License 2000 - 2024
SC State Medical License 1997 - 2013
CT State Medical License 1995 - 2000
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy Start of enrollment: 2009 Mar 01
Terminated
Phase 2
Vitamin D3 for Aromatase Inhibitor Induced Arthralgias Start of enrollment: 2009 Mar 01
Completed
Phase 2
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. Start of enrollment: 2009 May 01
Completed
Phase 2
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression Start of enrollment: 2009 Jul 01
Completed
Phase 2
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer Start of enrollment: 2011 Feb 01
Unknown status
Phase 2
A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer Start of enrollment: 2011 Feb 01
Completed
Phase 1
A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01
Completed
Phase 2, Phase 3
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer Start of enrollment: 2013 Oct 22
Active, not recruiting
Phase 1, Phase 2
A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer Start of enrollment: 2014 Feb 28
Completed
Phase 1
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Start of enrollment: 2015 Jun 09
Completed
Phase 3
Capecitabine in Metastatic Breast and GI Cancers Start of enrollment: 2015 Oct 05
Active, not recruiting
Phase 2
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer Start of enrollment: 2016 Feb 01
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain...> ;JAMA Network Open. 2023 Dec 1
8 citations
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Qamar J Khan, Anne P O'Dea, Lauren E Nye, Manana Elia, Jaimie Heldstab, Trisha Home...> ;NPJ Breast Cancer. 2023 Mar 6
Bolstering the complex study start-up process at NCI cancer centers using technology.
Dinesh Pal Mudaranthakam, Sam Pepper, Alexander Alsup, Tara Lin, Natalie Streeter, Jeffrey Thompson, Byron Gajewski, Matthew S Mayo, Qamar Khan> ;Contemporary Clinical Trials Communications. 2022 Dec 1
6 citations
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Elias, A., Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S...> ;NPJ Breast Cancer. 2022 Dec 1
17 citations
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.
Rachel Yoder, Bruce F Kimler, Joshua M Staley, Kelsey Schwensen, Yen Y Wang, Karissa Finke, Anne O'Dea, Lauren Nye, Manana Elia, Gregory Crane, Richard McKittrick, Rob...> ;NPJ Breast Cancer. 2022 Jul 11
13 citations
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant.
Qamar J Khan, Cory R Bivona, Grace A Martin, Jun Zhang, Ben Liu, Jianghua He, Kevin H Li, Maggie Nelson, Stephen Williamson, Gary C Doolittle, Weijing Sun, Dinesh Pal ...> ;JAMA Oncology. 2022 Jul 1
3 citations
Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients.
Qamar J Khan, Cory R Bivona, Ben Liu, Maggie Nelson, Grace A Martin, Muhammad Umair Mushtaq, Priyanka Sharma, Natalie R Streeter, Marc Hoffmann, Gary C Doolittle, Cunc...> ;Bone Marrow Transplantation. 2022 Jun 1
9 citations
Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study.
Anthony Rooney, Cory Bivona, Ben Liu, David Streeter, Han Gong, Qamar Khan> ;Journal of Hematology & Oncology. 2022 May 21
12 citations
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero-Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kath...> ;NPJ Breast Cancer. 2021 Oct 5
37 citations
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...
W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein, Lajos Pusztai, Rita Nanda, Barbara A. Parker, Brian Datnow, Gregor Krings, Shi Wei, Mi...> ;JAMA Oncology. 2021 Sep 16
23 citations
Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy
Jason I. Griffiths, Jinfeng Chen, Patrick A. Cosgrove, Anne O'Dea, Priyanka Sharma, Cynthia X. Ma, Meghna S. Trivedi, Kevin Kalinsky, Kari B. Wisinski, Ruth O'Regan, I...> ;Nature Cancer. 2021 Jun 3
26 citations
Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer
Priyanka Sharma, Vandana G Abramson, Anne O'Dea, Lauren Nye, Ingrid A. Mayer, Harsh B. Pathak, Marc Hoffmann, Shane R. Stecklein, Manana Elia, Sharon Lewis, Jecinta Sc...> ;Clinical Cancer Research. 2021 Feb 18
43 citations
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer...
Priyanka Sharma, Bruce F. Kimler, Anne O'Dea, Lauren Nye, Yen Y. Wang, Rachel Yoder, Joshua M Staley, Lindsey Prochaska, Jamie L. Wagner, Amanda L. Amin, Kelsey E. Lar...> ;Clinical Cancer Research. 2021 Feb 15
99 citations
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Can...
Douglas Yee, Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain, Yunn Yi Chen, Gregor Krings, Shi Wei, Shuko Harada, Brian Datnow, Ol...> ;JAMA Oncology. 2020 Sep 1
4 citations
Acral vascular syndrome during an immune checkpoint inhibitor
Patrick O'Connor, Pooja Bhadbhade, Qamar Khan, Stephen K. Williamson> ;BMJ Case Reports. 2020 May 1
73 citations
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Priyanka Sharma, Sara López-Tarruella, José A. García-Sáenz, Qamar J. Khan, Henry L. Gomez, Aleix Prat, Fernando Salvador Moreno, Yolanda Jerez-Gilarranz, Agustí Barna...> ;Clinical Cancer Research. 2018 Dec 1
91 citations
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
Virginia F. Borges, Cristiano Ferrario, Nathalie Aucoin, Carla I. Falkson, Qamar Khan, Ian E. Krop, Stephen Welch, Alison Conlin, Jorge Chaves, Philippe L. Bedard, Mar...> ;JAMA Oncology. 2018 Sep 1
47 citations
Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions
Lyndsey J. Kilgore, S. Korentager, Amanda N. Hangge, Amanda L. Amin, Christa R. Balanoff, Kelsey E. Larson, Melissa Mitchell, John Chen, Emily Burgen, Qamar J. Khan, A...> ;Annals of Surgical Oncology. 2018 Jul 9
32 citations
Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.
Jennifer R. Klemp, Jamie S. Myers, Carol J. Fabian, Bruce F. Kimler, Qamar J. Khan, Susan M. Sereika, Annette L. Stanton> ;Supportive Care in Cancer. 2018 Feb 1
3 citations
Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Cor...
Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, David R. Hout, Rob Seitz, Daniel B. Bailey, Anne O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Kha...> ;JCO Precision Oncology. 2017 Aug 7
27 citations
Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial
Qamar J. Khan, Bruce F. Kimler, Pavan S. Reddy, Priyanka Sharma, Jennifer R. Klemp, Jennifer L. Nydegger, Hung-Wen Yeh, Carol J. Fabian> ;Breast Cancer Research and Treatment. 2017 Aug 2
124 citations
A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE...
Miguel Martin, Arlene Chan, L.Y. Dirix, Joyce O'Shaughnessy, Roberto Hegg, Alexey Manikhas, Mikhail Shtivelband, Petr Krivorotko, N. Batista López, M. Campone, M. Ruiz...> ;Annals of Oncology. 2017 Feb 1
109 citations
Adaptive Randomization of Neratinib in Early Breast Cancer.
John W Park, Minetta C Liu, Douglas Yee, Christina Yau, Laura J van 't Veer, W Fraser Symmans, Melissa Paoloni, Jane Perlmutter, Nola M Hylton, Michael Hogarth, Angela...> ;The New England Journal of Medicine. 2016 Jul 7
393 citations
Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer
Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele, Christina Yau, Laura J. van't Veer, Meredith Buxton, Michael Hogarth, Nola M. Hylton, Melissa Paoloni, Jane Pe...> ;The New England Journal of Medicine. 2016 Jul 6
95 citations
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts.
Priyanka Sharma, Sara López-Tarruella, José A. García-Sáenz, Claire Ward, Carol S. Connor, Henry L. Gomez, Aleix Prat, Fernando Salvador Moreno, Yolanda Jerez-Gilarran...> ;Clinical Cancer Research. 2017 Feb 1
Join now to see all

Journal Articles

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Amanda Amin, Jamie Wagner, Qamar J Khan, Roy A Jensen, Joshua M Mammen, Priyanka Sharma, Jennifer R Klemp, Clinical Cancer Research

Hospital Affiliations

The University of Kansas HospitalKansas City, Kansas